Why is Chemo Pharma Lab falling/rising?

As of 24-Jul, Chemo Pharma Laboratories Ltd's stock price is currently at 131.55, reflecting a decrease of 3.45, or 2.56%. The stock has been underperforming recently, having fallen for the last two days with a total decline of 4.92%. It opened the day with a significant loss of 4.89% and reached an intraday low of Rs 128.4. Despite this, the stock has shown strong performance over longer periods, with a year-to-date increase of 19.77% and an impressive 81.45% rise over the past year. Notably, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend over the longer term. Additionally, there has been a rise in investor participation, with delivery volume increasing by 17% compared to the 5-day average, suggesting ongoing interest despite the recent price drop. In the broader market context, Chemo Pharma's short-term performance contrasts with the Sensex, which has seen a slight decline of 0.09% over the past week. While the stock has underperformed its sector by 2% today, its longer-term returns significantly outpace the benchmark, highlighting its strong historical performance. The liquidity of the stock remains adequate for trading, which may help stabilize its price in the face of recent volatility. Overall, the combination of recent price declines, while still maintaining a strong long-term performance, reflects a complex situation influenced by both market sentiment and investor behavior.